FAVUS ELLIOT

Track

Insider profile

Performance

Overall performance
1.2
Performance over holding periods
1.2
30 days 90 days 120 days
Average return -65% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
FAVUS ELLIOT's trades of Anavex Life Sciences Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-05-25 2021-05-21
S Sale
36,786 +5.5%
353.59
US$1,487,281 		36,786 +5.5% 353.59 US$1,487,281
2021-02-26 2021-02-24
S Sale
28,485 +3.1%
53.39
US$2,257,861 		28,485 +3.1% 53.39 US$2,257,861